SDGR News
Schrdinger to Announce Third Quarter 2026 Financial Results on November 4
Schrdinger, Inc. (Nasdaq: SDGR) will report its third quarter 2026 financial results on Wednesday, November 4, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. The live webcast can be accessed in the Investors section of Schrdingers...
Business Wire
Schrdinger to Announce Third Quarter 2026 Financial Results on November 4
Schrdinger, Inc. (Nasdaq: SDGR) will report its third quarter 2026 financial results on Wednesday, November 4, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. The live webcast can be accessed in the Investors section of Schrdingers...
Business Wire
Schrdinger Research Published in Nature Reveals New Insights into Lithium-Ion Battery Chemistry
Schrdinger, Inc. (Nasdaq: SDGR) today announced the publication of new research in Nature that reveals critical insights into the atomic-scale structure of lithium-ion battery (LIB) electrolytes. In a joint study with researchers from Columbia University and the New York Structural Biology Center...
Business Wire
Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains?
Schrodinger (SDGR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?
RXRX's strategic partnerships are expanding its drug pipeline, strengthening AI capabilities and providing non-dilutive funding through early 2028.
Zacks
SOPHiA GENETICS (SOPH) Moves 7.0% Higher: Will This Strength Last?
SOPHiA GENETICS (SOPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
Closing Power Hour: Biotech, AI, Energy and Crypto Stories Take Center Stage
The final stretch of trading is bringing a fresh batch of catalysts across biotech, energy, AI and digital assets, with the following names delivering developments capable of reshaping their narratives. Aethlon Medical (NASDAQ:AEMD), NeOnc Technologies Holdings (NASDAQ:NTHI), bioAffinity Technologies (NASDAQ:BIAF), Turbo Energy (NASDAQ:TURB), CID HoldCo (NASDAQ:DAIC), Paradium.AI (NYSE:PAAI), StablecoinX (NASDAQ:USDE), FuelCell Energy (NASDAQ:FCEL), and Schrödinger (NASDAQ:SDGR).
24-7 Market News
Schrdinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Schrdinger, Inc. (Nasdaq: SDGR) today reported that on September 13, 2026, the company granted restricted stock units (RSUs) with respect to 2,243 shares of the companys common stock to three newly hired employees. These grants were made pursuant to the companys 2021 Inducement Equity Incentive...
Business Wire
SDGR Crosses Above Average Analyst Target
In recent trading, shares of Schrodinger Inc (Symbol: SDGR) have crossed above the average analyst 12-month target price of $21.43, changing hands for $23.25/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valu...
Nasdaq News: Markets
Schrodinger (SDGR) Soars 12.1%: Is Further Upside Left in the Stock?
Schrodinger (SDGR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033 AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033PR NewswireAUSTIN, Texas, Sept. 14, 2026 AUSTIN, Texas, Sept. 14, 2026 /PRNewswire/ -- USA News Group News Commentary- Artificial intelligence is moving from the edges...
PR Newswire